SYNTIS BIO, INC. — Form D
SYNTIS BIO, INC. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2025-07-02. The offering totals $26.5M, of which $25.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-07-02
- Form: D
- Accession: 0001943061-25-000005
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $26.5M
- Amount sold: $25.0M
- Remaining: $1.5M
- Investors: 12
- Date of first sale: 2025-06-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-550616
Issuer
- Name: SYNTIS BIO, INC.
- CIK: 0001943061
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 135 MORRISSEY BLVD, BOSTON, MA, 02125
- Phone: 857-675-1109
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Teymour Boutros-Ghali | Director | Santa Monica, CA |
| Rahul Dhanda | Director | Cambridge, MA |
| Robert Langer | Director | Pittsburgh, PA |
| Martin Madaus | Director | Boston, MA |
| Michael Nannizzi | Director | Boston, MA |
| Carlo Giovanni Traverso | Director | Allston, MA |
| Chenny Zhang | Director | San Diego, CA |
| Rahul Dhanda | Executive Officer | Cambridge, MA |
| Carlo Giovanni Traverso | Director | Watertown, MA |
| Robert Giovanni Langer | Director | Watertown, MA |
| MARTIN GIOVANNI MADAUS | Director | MILTON, MA |
| RAHUL K DHANDA | Director | MILTON, MA |
| RAHUL K DHANDA | Executive Officer | MILTON, MA |
| TEYMOUR GIOVANNI BOUTROS-GHALI | Director | MILTON, MA |
Other filings by this issuer (3)
More